US2009227038A1PendingUtilityA1
Methods of determining skeletal maturity
Individually held — no corporate assignee on recordPriority: Apr 6, 2006Filed: Apr 5, 2007Published: Sep 10, 2009
Est. expiryApr 6, 2026(expired)· nominal 20-yr term from priority
Inventors:Mohamed I. Masoud
G01N 33/6893G01N 2800/10G01N 33/68G01N 2333/475
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides methods to determine skeletal maturity.
Claims
exact text as granted — not AI-modified1 . A method of determining skeletal maturity in a subject, comprising measuring the level of IGF-1 in a tissue or fluid sample, wherein an elevated level of IGF-1 post-puberty indicates that said subject has not reached skeletal maturity.
2 . The method of claim 1 , wherein said level of IGF-1 post-puberty exceeds 250 μg/L.
3 . The method of claim 1 , wherein said subject is suffering from or at risk of developing a mandibular or facial growth abnormality.
4 . The method of claim 1 , wherein said method does not comprise x-ray examination of a cervical vertebra.
5 . A method of identifying the skeletal maturity stage of a mammal, comprising the steps of: determining the level of IGF-1 in said sample, wherein levels ranging between 140 and 260 ug/L indicates that a mammal in prepubertal stage is at cervical stage (CS) 1 or CS2, levels ranging between 270 and 320 ug/L indicates that a mammal in early pubertal stage is at CS3, levels ranging between 320 and 380 ug/L indicates that a mammal in pubertal stage is at CS4, levels ranging between 380 and 500 ug/L indicates that a mammal in late pubertal stage is at CS5, and levels ranging between 200 and 400 ug/L indicates that a mammal in post pubertal stage is at CS6
6 . The method of claim 5 , wherein a mammal having IGF-1 levels ranging between 260 and 500 ug/L and identified as being at CS1, CS2, CS3, CS4, or CS5 is selected as a candidate for a medical procedure that involves residual bone growth in said mammal.
7 . The method of claim 5 , wherein a mammal having IGF-1 levels below 280 ug/L and identified as being at CS6 is selected as a candidate for a medical procedure that does not involve residual bone growth.
8 . The method of claim 6 or 7 , wherein said bone growth is facial bone growth.
9 . The method of claim 8 , wherein said facial bone growth is mandibullar growth.
10 . The method of claim 6 or 7 , wherein said medical procedure is a dental procedure.
11 . The method of claim 10 , wherein said dental procedure is an orthodontic procedure.
12 . The method of claim 10 , wherein said dental procedure is a tooth implant.
13 . The method of claim 1 , wherein said biological sample is serum, blood, or saliva.
14 . The method of claim 13 , wherein said blood is obtained by blood spotting.
15 . The method of claim 5 , further comprising obtaining a hand-wrist radiograph from said mammal.
16 . The method of claim 15 , wherein said hand wrist radiograph is evaluated using the Greulich and Pyle technique or the Fishman technique.
17 . The method of claim 5 , wherein said mammal is a human.
18 . The method of claim 5 , wherein pre-pubertal stage, pubertal stage, late pubertal stage, and post-pubertal stage are identified by physical characteristic of said mammal.
19 . The method of claim 18 , wherein said physical characteristic is a sexual characteristic.
20 . The method of claim 5 , wherein said pre-pubertal stage, pubertal stage, late pubertal stage, and post-pubertal stage are identified by the chronological age of said mammal.
21 . A method of identifying the skeletal maturity stage of a mammal, comprising the steps of:
(a) providing a biological sample from a mammal; (b) determining the level of IGF-1 in said sample; and (c) repeating steps (a) and (b) at one or more time intervals, wherein an increase in IGF-1 levels over time indicates that said mammal is between cervical stage CS1 and CS5 and a reduction of IGF-1 levels over time indicates that said mammal is between CS5 and CS6.
22 . The method of claim 21 , wherein said repeating is performed approximately every year from the time said mammal is in prepubertal stage.
23 . The method of claim 22 , wherein said repeating is performed approximately every six months.
24 . The method of claim 21 , wherein a mammal whose IGF-1 levels are increasing over time and is identified as being at CS1, CS2, CS3, CS4, or CS5 is selected as a candidate for a medical procedure that involves residual bone growth in said mammal.
25 . The method of claim 21 , wherein a mammal identified as being at CS6 and whose IGF-1 levels are less than 280 ug/L is selected as a candidate for a medical procedure that does not involve residual bone growth.
26 . The method of claim 24 or 25 , wherein said bone growth is facial bone growth.
27 . The method of claim 26 , wherein said facial bone growth is mandibullar growth.
28 . The method of claim 24 or 25 , wherein said medical procedure is a dental procedure.
29 . The method of claim 28 , wherein said dental procedure is an orthodontic procedure.
30 . The method of claim 28 , wherein said dental procedure is a tooth implant.
31 . The method of claim 21 , wherein said biological sample is serum, blood, or saliva.
32 . The method of claim 31 , wherein said blood is obtained by blood spotting.
33 . The method of claim 21 , further comprising obtaining a hand-wrist radiograph from said mammal.
34 . The method of claim 33 , wherein said hand wrist radiograph is evaluated using the Greulich and Pyle technique or the Fishman technique.
35 . The method of claim 21 , wherein said mammal is a human.
36 . The method of claim 21 , wherein pre-pubertal stage, pubertal stage, late pubertal stage, and post-pubertal stage are identified by physical characteristic of said mammal.
37 . The method of claim 36 , wherein said physical characteristic is a sexual characteristic.
38 . The method of claim 21 , wherein said pre-pubertal stage, pubertal stage, late pubertal stage, and post-pubertal stage are identified by the chronological age of said mammal.Join the waitlist — get patent alerts
Track US2009227038A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.